513 related articles for article (PubMed ID: 9865696)
1. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
[TBL] [Abstract][Full Text] [Related]
2. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
Runyan CE; Schnaper HW; Poncelet AC
J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of Smad2 recognition by the Smad anchor for receptor activation.
Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y
Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055
[TBL] [Abstract][Full Text] [Related]
4. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2.
Hayes S; Chawla A; Corvera S
J Cell Biol; 2002 Sep; 158(7):1239-49. PubMed ID: 12356868
[TBL] [Abstract][Full Text] [Related]
5. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling.
Itoh F; Divecha N; Brocks L; Oomen L; Janssen H; Calafat J; Itoh S; Dijke Pt Pt
Genes Cells; 2002 Mar; 7(3):321-31. PubMed ID: 11918675
[TBL] [Abstract][Full Text] [Related]
6. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
9. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.
Hayashi H; Abdollah S; Qiu Y; Cai J; Xu YY; Grinnell BW; Richardson MA; Topper JN; Gimbrone MA; Wrana JL; Falb D
Cell; 1997 Jun; 89(7):1165-73. PubMed ID: 9215638
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
11. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells.
Dooley S; Delvoux B; Streckert M; Bonzel L; Stopa M; ten Dijke P; Gressner AM
FEBS Lett; 2001 Jul; 502(1-2):4-10. PubMed ID: 11478938
[TBL] [Abstract][Full Text] [Related]
13. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
[TBL] [Abstract][Full Text] [Related]
16. The Smad pathway.
Wrana JL; Attisano L
Cytokine Growth Factor Rev; 2000; 11(1-2):5-13. PubMed ID: 10708948
[TBL] [Abstract][Full Text] [Related]
17. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster.
Bennett D; Alphey L
Nat Genet; 2002 Aug; 31(4):419-23. PubMed ID: 12134149
[TBL] [Abstract][Full Text] [Related]
18. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
Tsang KJ; Tsang D; Brown TN; Crowe DL
Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase class II α-isoform PI3K-C2α is required for transforming growth factor β-induced Smad signaling in endothelial cells.
Aki S; Yoshioka K; Okamoto Y; Takuwa N; Takuwa Y
J Biol Chem; 2015 Mar; 290(10):6086-105. PubMed ID: 25614622
[TBL] [Abstract][Full Text] [Related]
20. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
Kretzschmar M; Doody J; Timokhina I; Massagué J
Genes Dev; 1999 Apr; 13(7):804-16. PubMed ID: 10197981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
